Current status, Challenges and Future Directions of drug-eluting Balloons

• Mueller RL , SanbornTA. The history of interventional cardiology: cardiac catheterization, angioplasty, and related interventions. Am. Heart J., 129(1), 146–172 (1995).
   PubMed Web of Science ®Google Scholar
• Erbel R , HaudeM, HöppHWet al. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. N. Engl. J. Med. , 339(23), 1672–1678 (1998).
   PubMed Web of Science ®Google Scholar
• Serruys PW et al. , de Jaegere P, Kiemeneij F A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N. Engl. J. Med., 331(8), 489–495 (1994).
   PubMed Web of Science ®Google Scholar
• Hoffmann R , MintzGS, DussaillantGRet al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation , 94(6), 1247–1254 (1996).
   PubMed Web of Science ®Google Scholar
• Moses JW , LeonMB, PopmaJJet al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med. , 349(14), 1315–1323 (2003).
   PubMed Web of Science ®Google Scholar
• Stone GW , EllisSG, CannonLet al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA , 294(10), 1215–1223 (2005).
   PubMed Web of Science ®Google Scholar
• Camenzind E , StegPG, WijnsW. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation, 115(11), 1440–1455 discussion 1455 (2007).
   PubMed Web of Science ®Google Scholar
• Stone GW , MosesJW, EllisSGet al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N. Engl. J. Med. , 356(10), 998–1008 (2007).
   PubMed Web of Science ®Google Scholar
• Kelsch B , SchellerB, BiedermannMet al. Dose response to paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model. Invest. Radiol. , 46(4), 255–263 (2011).
   PubMed Web of Science ®Google Scholar
• Scheller B , SpeckU, AbramjukC, BernhardtU, BohmM, NickenigG. Paclitaxel balloon coating, a novel method ~for prevention and therapy of restenosis. Circulation, 110(7), 810–814 (2004).
   PubMed Web of Science ®Google Scholar
• Lovich MA , EdelmanER. Mechanisms of transmural heparin transport in the rat abdominal aorta after local vascular delivery. Circ. Res., 77(6), 1143–1150 (1995).
   PubMed Web of Science ®Google Scholar
• Cremers B , SpeckU, KaufelsNet al. Drug-eluting balloon: very short-term exposure and overlapping. Thromb. Haemost. , 101(1), 201–206 (2009).
   PubMed Web of Science ®Google Scholar
• Axel DI , KunertW, GoggelmannCet al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation , 96(2), 636–645 (1997).
   PubMed Web of Science ®Google Scholar
• Herdeg C , OberhoffM, BaumbachAet al. Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J. Am. Coll. Cardiol. , 35(7), 1969–1976 (2000).
   PubMed Web of Science ®Google Scholar
• Creel CJ , LovichMA, EdelmanER. Arterial paclitaxel distribution and deposition. Circ. Res., 86(8), 879–884 (2000).
   PubMed Web of Science ®Google Scholar
• Speck U , SchellerB, AbramjukC, BernhardtU. Drug delivery by angiographic contrast media: inhibition of restenosis. Acad. Radiol., 12(Suppl. 1), S14–S17 (2005).
   PubMedGoogle Scholar
• Cremers B , CleverY, SchaffnerS, SpeckU, BohmM, SchellerB. Treatment of coronary in-stent restenosis with a novel paclitaxel urea coated balloon. Minerva Cardioangiol., 58(5), 583–588 (2010).
   PubMed Web of Science ®Google Scholar
• Donaldson KL , GoolsbyGL, KienerPA, WahlAF. Activation of p34cdc2 coincident with taxol-induced apoptosis. Cell. Growth Differ., 5(10), 1041–1050 (1994).
   PubMedGoogle Scholar
• Buerke M , GuckenbiehlM, SchwertzHet al. Intramural delivery of Sirolimus prevents vascular remodeling following balloon injury. Biochim. Biophys. Acta , 1774(1), 5–15 (2007).
   PubMed Web of Science ®Google Scholar
• Levin AD , VukmirovicN, HwangCW, EdelmanER. Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. Proc. Natl Acad. Sci. USA, 101(25), 9463–9467 (2004).
   PubMed Web of Science ®Google Scholar
• Chen YW , SmithML, SheetsMet al. Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppression. J. Cardiovasc. Pharmacol. , 49(4), 228–235 (2007).
   PubMed Web of Science ®Google Scholar
• Sheiban I , AnselminoM, MorettiCet al. Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteries. Clin. Res. Cardiol. , 97(12), 891–898 (2008).
   PubMed Web of Science ®Google Scholar
• Tharp DL , WamhoffBR, WulffH, RamanG, CheongA, BowlesDK. Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis. Arterioscler. Thromb. Vasc. Biol., 28(6), 1084–1089 (2008).
   PubMed Web of Science ®Google Scholar
• Fanggiday JC , StellaPR, GuyomiSH, DoevendansPA. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (Drug-Eluting Balloon In Bifurcation Utrecht) registry. Catheter. Cardiovasc. Interv., 71(5), 629–635 (2008).
   PubMed Web of Science ®Google Scholar
• Dommke C , HaaseKK, SuselbeckTet al. Local paclitaxel delivery after coronary stenting in an experimental animal model. Thromb. Haemost. , 98(3), 674–680 (2007).
   PubMed Web of Science ®Google Scholar
• Albrecht T , SpeckU, BaierC, WolfKJ, BohmM, SchellerB. Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine. Invest. Radiol., 42(8), 579–585 (2007).
   PubMed Web of Science ®Google Scholar
• Nakamura T , BrottBC, BrantsIet al. Vasomotor function after paclitaxel-coated balloon post-dilation in porcine coronary stent model. JACC Cardiovasc. Interv. , 4(2), 247–255 (2011).
   PubMed Web of Science ®Google Scholar
• Joner M , ByrneRA, LapointeJMet al. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis. Thromb. Haemost. , 105(5), 864–872 (2011).
   PubMed Web of Science ®Google Scholar
• Scheller B , HehrleinC, BockschWet al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N. Engl. J. Med. , 355(20), 2113–2124 (2006).
   PubMed Web of Science ®Google Scholar
• Scheller B , HehrleinC, BockschWet al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin. Res. Cardiol. , 97(10), 773–781 (2008).
   PubMed Web of Science ®Google Scholar
• Unverdorben M , VallbrachtC, CremersBet al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation , 119(23), 2986–2994 (2009).
   PubMed Web of Science ®Google Scholar
• Rosenkranz S , MaierLS, MaackC, BohmM. Hotline update of clinical trials and registries presented at the German Cardiac Society meeting 2007: 2L-Registry, Kardio-Pro, EVER, AFFECT, VTACH, ARTS II, OPTAMI, PEPCAD I, PEPCAD II, GERSHWIN, SPICE, FIX-CHF and CREDIT. Clin. Res. Cardiol., 96(7), 457–468 (2007).
   PubMed Web of Science ®Google Scholar
• Hehrlein C , RichardtG, WiemerMet al. International first in man trial with novel drug eluting balloon in patients presenting with in-stent restenosis (PEPPER). J. Am. Coll. Cardiol. , 57(Suppl. 14), E1640 (2011).
   Web of Science ®Google Scholar
• Maier LS , MaackC, RitterO, BohmM. Hotline update of clinical trials and registries presented at the German Cardiac Society meeting 2008. (PEPCAD, LokalTax, INH, German ablation registry, German device registry, DES.DE registry, DHR, Reality, SWEETHEART registry, ADMA, GERSHWIN). Clin. Res. Cardiol., 97(6), 356–363 (2008).
   PubMed Web of Science ®Google Scholar
• Cortese B , MicheliA, PicchiAet al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart , 96(16), 1291–1296 (2010).
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Chico JL et al. , van Geuns RJ, Koch K Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. EuroIntervention, 7(6), 711–722 (2011).
   PubMed Web of Science ®Google Scholar
• Herdeg C , GeislerT, Goehring-FrischholzKet al. Catheter-based local antiproliferative therapy in kissing balloon technique for in-stent stenosis of coronary artery bifurcation lesions. Can. J. Cardiol. , 24(4), 309–311 (2008).
   PubMed Web of Science ®Google Scholar
• Sgueglia GA , TodaroD, BiscigliaA, ConteM, StipoA, PucciE. Kissing inflation is feasible with all second-generation drug-eluting balloons. Cardiovasc. Revasc. Med., 12(5), 280–285 (2011).
   PubMedGoogle Scholar
• Mathey DG , WendigI, BoxbergerM, BonaventuraK, KleberFX. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. EuroIntervention, 7, K61–K65 (2011).
   PubMed Web of Science ®Google Scholar
• Tepe G , ZellerT, AlbrechtTet al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N. Engl. J. Med. , 358(7), 689–699 (2008).
   PubMed Web of Science ®Google Scholar
• Werk M , LangnerS, ReinkensmeierBet al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation , 118(13), 1358–1365 (2008).
   PubMed Web of Science ®Google Scholar
• Posa A , HemetsbergerR, PetnehazyOet al. Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries. Coron. Artery Dis. , 19(4), 243–247 (2008).
   PubMed Web of Science ®Google Scholar
• Herdeg C , Gohring-FrischholzK, HaaseKKet al. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation. Circ. Cardiovasc. Interv. , 2(4), 294–301 (2009).
   PubMed Web of Science ®Google Scholar

Websites

• Cotavance drug-eluting balloon angioplasty catheter www.medrad.com/en-us/newsroom/press/Pages/UniqueCardiovasculartreatment.aspx (Accessed April172011)
   Google Scholar
• IN.PACT drug coated balloon series www.invatec.com/tool/home.php?s=0,1,55 (Accessed April172011)
   Google Scholar
• Pantera lux paclitaxel-releasing balloon www.biotronik.com/en/se/24250 (Accessed April172011)
   Google Scholar
• Drug Eluting Pantera Lux Catheter Registry http://clinicaltrials.gov/ct2/show/NCT01081366
   Google Scholar
• Efficacy Study of Kissing Drug Eluting Balloons in Coronary Bifurcation Lesions (KISSING DEBBIE) http://clinicaltrials.gov/ct2/show/NCT01009996
   Google Scholar
• Study of IN.PACT Amphirion™ Drug Eluting Balloon vs Standard PTA for the Treatment of Below the Knee Critical Limb Ischemia (INPACT-DEEP) http://clinicaltrials.gov/ct2/show/NCT00941733
   Google Scholar
• LEVANT I trial http://clinicaltrials.gov/ct2/showNCT00930813
   Google Scholar